Literature DB >> 9329160

Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine.

P Nestby1, A Schotte, P F Janssen, G H Tjon, L J Vanderschuren, T J De Vries, A H Mulder, J E Leysen, A N Schoffelmeer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329160     DOI: 10.1002/(SICI)1098-2396(199711)27:3<262::AID-SYN10>3.0.CO;2-W

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


× No keyword cloud information.
  6 in total

1.  Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice.

Authors:  J R Fee; D R Sparta; M J Picker; T E Thiele
Journal:  Neuroscience       Date:  2007-09-08       Impact factor: 3.590

2.  Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization.

Authors:  Thierry Le Marec; Cynthia Marie-Claire; Florence Noble; Nicolas Marie
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

Review 3.  Activators of G-protein signaling 3: a drug addiction molecular gateway.

Authors:  Michael Scott Bowers
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

4.  Nicotine behavioral pharmacology: clues from planarians.

Authors:  Scott M Rawls; Tanvi Patil; Christopher S Tallarida; Steven Baron; Myongji Kim; Kevin Song; Sara Ward; Robert B Raffa
Journal:  Drug Alcohol Depend       Date:  2011-05-06       Impact factor: 4.492

5.  Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment.

Authors:  Stéphane Allouche; Thierry Le Marec; Antoine Coquerel; Florence Noble; Nicolas Marie
Journal:  Psychopharmacology (Berl)       Date:  2014-10-31       Impact factor: 4.530

6.  First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians.

Authors:  Scott M Rawls; Tavni Patil; Ekaternia Yuvasheva; Robert B Raffa
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.